Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure with lifelong benefits for most patients.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/glp-1s-dominate-headlines-obesity-surgery-wins-cost-2025a1000t06?src=rss
Author :
Publish date : 2025-10-24 11:28:00
Copyright for syndicated content belongs to the linked Source.